Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS3A pseudogene 16 is a non-coding genetic element classified as a processed pseudogene of the ribosomal protein S3A gene (RPS3A)[2]. Unlike its parent gene, RPS3AP16 does not code for a functional ribosomal protein and lacks protein-coding potential due to sequence disablements such as frameshifts or premature stop codons[2]. Pseudogenes like RPS3AP16 are the result of retrotransposition events and are dispersed throughout the genome, with no evidence they play a direct role in protein synthesis or cell biology[2]. Such pseudogenes are common for ribosomal protein families, but they are not known to be involved in any therapeutic mechanism, disease process, or drug interaction[2][5][6]. If you require detailed information about the functional gene RPS3A or its protein product, which has established biological roles and potential disease relevance, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 16 (RPS3AP16).